SCHEMBL19334357

SCHEMBL19334357

O=C(O)c1ccccc1Nc1ccc([N+](=O)O)c2nonc12

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MYC P01106 10/20 0.80
▸ MEN1 O00255 7/20 0.80
▸ KMT2A Q03164 7/20 0.80
▸ MAX P61244 5/20 0.60
▸ POLB P06746 1/20 0.55
▸ GAA P10253 1/20 0.55
▸ L3MBTL1 Q9Y468 1/20 0.55
▸ IDO1 P14902 1/20 0.52
▸ GSTP1 P09211 1/20 0.46
▸ GSTM2 P28161 1/20 0.46
▸ USP2 O75604 1/20 0.46
▸ HTT P42858 1/20 0.46
▸ RECQL P46063 1/20 0.46
▸ FABP4 P15090 1/20 0.46
▸ CDC25B P30305 1/20 0.44
▸ AKR1C3 P42330 3/20 0.44
▸ AKR1C2 P52895 3/20 0.44
▸ AKR1B1 P15121 2/20 0.44
▸ AKR1C4 P17516 2/20 0.44
▸ AKR1C1 Q04828 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13401376 0.89 MYC (1.00) MYCMEN1KMT2AMAXPOLB
SCHEMBL17934450 0.78 MYC (0.80) MYCMEN1KMT2AMAXPOLB
SCHEMBL17927364 0.74 MYC (0.72) MYCMEN1KMT2AMAXPOLB
SCHEMBL17927368 0.74 MYC (0.72) MYCMEN1KMT2AMAXPOLB
SCHEMBL19334344 0.72 IDO1 (0.76) MYCMEN1KMT2AMAXPOLB
SCHEMBL17927401 0.72 MYC (0.69) MYCMEN1KMT2AMAXPOLB
SCHEMBL355549 0.72 FABP4 (0.80) MEN1KMT2AUSP2RECQLFABP4
SCHEMBL30320327 0.72 FABP4 (0.80) MEN1KMT2AUSP2RECQLFABP4
SCHEMBL2464366 0.71 MEN1 (1.00) MYCMEN1KMT2AMAXPOLB
SCHEMBL16107852 0.71 MEN1 (0.72) MYCMEN1KMT2AMAXPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9757375-B2 Compounds that inhibit human DNA ligases and methods of treating cancer UNIVERSITY OF MARYLAND, BALTIMORE (US) 2017-09-12 — — US disclosed
Send feedback